These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11950000)

  • 21. Pulmonary infections in patients with rheumatoid arthritis who have received anti-TNF therapy.
    Amano K
    Intern Med; 2006; 45(17):991-2. PubMed ID: 17015997
    [No Abstract]   [Full Text] [Related]  

  • 22. Guillain-Barré syndrome in a patient receiving anti-tumour necrosis factor alpha for rheumatoid arthritis: a case report and discussion of literature.
    Silburn S; McIvor E; McEntegart A; Wilson H
    Ann Rheum Dis; 2008 Apr; 67(4):575-6. PubMed ID: 18349168
    [No Abstract]   [Full Text] [Related]  

  • 23. Infliximab and reactivation of cerebral toxoplasmosis.
    Young JD; McGwire BS
    N Engl J Med; 2005 Oct; 353(14):1530-1; discussion 1530-1. PubMed ID: 16207863
    [No Abstract]   [Full Text] [Related]  

  • 24. Adalimumab: new preparation. Rheumatoid arthritis: no therapeutic advance.
    Prescrire Int; 2004 Oct; 13(73):171-5. PubMed ID: 15499697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart failure on infliximab.
    Prescrire Int; 2002 Jun; 11(59):86-7. PubMed ID: 12068846
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
    Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I
    Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278
    [No Abstract]   [Full Text] [Related]  

  • 27. Infliximab-induced SLE-like syndrome involving the lung and pleura.
    Diri E; Tello W; Ratnoff WD; Nugent K
    Lupus; 2007; 16(9):764-6. PubMed ID: 17728373
    [No Abstract]   [Full Text] [Related]  

  • 28. Infectious complications of biologic agents.
    Martin-Mola E; Balsa A
    Rheum Dis Clin North Am; 2009 Feb; 35(1):183-99. PubMed ID: 19481004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor-alpha blockade and the risk of vasculitis.
    Guillevin L; Mouthon L
    J Rheumatol; 2004 Oct; 31(10):1885-7. PubMed ID: 15468348
    [No Abstract]   [Full Text] [Related]  

  • 30. The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis.
    Hansen KE; Hildebrand JP; Genovese MC; Cush JJ; Patel S; Cooley DA; Cohen SB; Gangnon RE; Schiff MH
    J Rheumatol; 2004 Jun; 31(6):1098-102. PubMed ID: 15170921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sepsis of a prosthetic joint and biological therapies.
    Fernández-Castro M; Andreu JL; Muñoz P; Silva L
    Rheumatology (Oxford); 2005 Aug; 44(8):1076-7; author reply 1075. PubMed ID: 15840593
    [No Abstract]   [Full Text] [Related]  

  • 32. Infliximab treatment of rheumatoid arthritis.
    Maini SR
    Rheum Dis Clin North Am; 2004 May; 30(2):329-47, vii. PubMed ID: 15172044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serious lung disease in RA and TNF-blockade--is there a connection?].
    Turesson C; Jacobsson L; Saxne T; Geborek P
    Lakartidningen; 2006 Feb 1-7; 103(5):308; author reply 308-9. PubMed ID: 16512575
    [No Abstract]   [Full Text] [Related]  

  • 34. Rheumatoid arthritis and herpes zoster: risk and prevention in those treated with anti-tumour necrosis factor therapy.
    Winthrop KL; Furst DE
    Ann Rheum Dis; 2010 Oct; 69(10):1735-7. PubMed ID: 20858622
    [No Abstract]   [Full Text] [Related]  

  • 35. Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, crossover study in patients with chronic arthritis.
    Lazzerini PE; Acampa M; Hammoud M; Maffei S; Capecchi PL; Selvi E; Bisogno S; Guideri F; Galeazzi M; Pasini FL
    J Rheumatol; 2008 Oct; 35(10):1958-65. PubMed ID: 18709695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative overview of safety of the biologics in rheumatoid arthritis.
    Khraishi M
    J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [TNF-alpha antibody in rheumatoid arthritis. Efficacy-risk relationship is positively evaluated].
    MMW Fortschr Med; 2002 May; 144(20):65. PubMed ID: 12119893
    [No Abstract]   [Full Text] [Related]  

  • 38. Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles.
    Ettefagh L; Nedorost S; Mirmirani P
    Arch Dermatol; 2004 Aug; 140(8):1012. PubMed ID: 15313825
    [No Abstract]   [Full Text] [Related]  

  • 39. Disseminated histoplasmosis associated with the treatment of rheumatoid arthritis with anticytokine therapy.
    Asrani NS
    Ann Intern Med; 2008 Oct; 149(8):594-5. PubMed ID: 18936512
    [No Abstract]   [Full Text] [Related]  

  • 40. Pneumocystis pneumonia associated with infliximab in Japan.
    Harigai M; Koike R; Miyasaka N;
    N Engl J Med; 2007 Nov; 357(18):1874-6. PubMed ID: 17978303
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.